|Podcasts|September 3, 2021

What Strategies Should Pharma and Biotech Firms Take to Adapt to the Evolving Central Lab Landscape in Post-COVID Era

Author(s)Frontage Labs

On a global scale, Frontage Central Lab Business is assisting clients with their drug development needs across all clinical phases. In this podcast, the Frontage Central lab team will discuss some of the best practices to keep in mind when choosing a lab partner for PK/PD and routine/specialty central lab support.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Content

Unlock Commercial Growth through Data-Driven Patient and HCP Insights Podcast

May 2nd 2025

Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit

February 7th 2025

Thinking Big for Small and Mid-Sized Biotechs: How Applying Modeling and Simulation Technologies Can Improve Drug Development

January 6th 2023

The Evolving Relationship Between Sponsors and the Contract Research Organizations

December 8th 2022

The MDR: Navigating Europe’s New Standard for Medical Device Safety

October 25th 2022

Trending on Applied Clinical Trials Online

One Clinical: Working Together to Advance Trial Collaboration

FDA Seeks Public Input on Regulatory Framework for Generative AI-Enabled Medical Devices

ACT Brief: Phase I Back-Office Automation Priorities, Early Phase Data Interpretation Under Capital Pressure, and Syneos AI Ecosystem Expansion

Syneos Health Expands AI Ecosystem With Three New Platform Partnerships

Avoiding Pitfalls When Every Patient Becomes a Readout